Share This Author
Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats
- J. Shoblock, Eric B. Sullivan, I. M. Maisonneuve, S. D. Glick
- Biology, PsychologyPsychopharmacology
- 1 February 2003
It is suggested that new pharmacotherapeutic agents that produce augmentations of NAC GLU or PFC DA activity, or perhaps inhibition of PFC GLU activity, may someday be useful for the treatment of METH addiction.
Kappa opioid inhibition of morphine and cocaine self-administration in rats
Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum
U50,488, a κ opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats
Effects and aftereffects of ibogaine on morphine self-administration in rats.
Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment
Rotational movement (circling) in normal humans: sex difference and relationship to hand, foot and eye preference
Inhibition of the mammalian target of rapamycin pathway by rapamycin blocks cocaine-induced locomotor sensitization
18‐Methoxycoronaridine (18‐MC) and Ibogaine: Comparison of Antiaddictive Efficacy, Toxicity, and Mechanisms of Action
- S. D. Glick, I. M. Maisonneuve, K. Szumlinski
- BiologyAnnals of the New York Academy of Sciences
- 1 September 2000
The data suggest that 18‐MC has a narrower spectrum of actions and will have a substantially greater therapeutic index than ibogaine, and is likely to have an active metabolite.